Tag: Neuropsychopharmacology

New Study Provides Proof of CBD’s Potential in Relapse Prevention

Results of a new study “provide proof of principle supporting potential of CBD in relapse prevention”. The study was published in the journal Neuropsychopharmacology, and epublished ahead of print by the U.S. National Institute of Health. “Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa, has received attention for therapeutic potential in treating neurologic and …

Continue reading

Study: Cannabidiol May Help Prevent Relapses in Those Addicted to Alcohol and Drugs

The findings of a study published last week by the journal Neuropsychopharmacology “provide proof of principle supporting potential of CBD [cannabidiol] in relapse prevention”. “Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa, has received attention for therapeutic potential in treating neurologic and psychiatric disorders”, states the study’s abstract. “Recently, CBD has also been explored for potential …

Continue reading

Study: Cannabinoids Can Prevent Post Traumatic Stress Disorder

Giving cannabinoids to an individual soon after they experience a traumatic event can prevent post traumatic stress disorder, according to a new University of Haifa study, which was published in the journal Neuropsychopharmacology. “The findings of our study suggest that the connectivity within the brain’s fear circuit changes following trauma, and the administration of cannabinoids …

Continue reading